Killing two kinase families with one stone

Nature Chemical Biology

Volumn 4, Issue 11, 2008, Pages 648-649

  Bilanges, Benoit ^a   Torbett, Neil ^b   Vanhaesebroeck, Bart ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b Piramed Pharma   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 (4 HYDROXYPHENYL) 4 MORPHOLINOPYRIDO[3',2':4,5]FURO[3,2 D]PYRIMIDINE; ANTINEOPLASTIC AGENT; IMATINIB; PHOSPHOTRANSFERASE; PP 121; SORAFENIB; SUNITINIB; UNCLASSIFIED DRUG;

CANCER CHEMOTHERAPY; CHRONIC MYELOID LEUKEMIA; DRUG ACTIVITY; DRUG DESIGN; DRUG SELECTIVITY; GASTROINTESTINAL TUMOR; GLIOMA; HUMAN; KIDNEY CANCER; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY;

EID: 54249158738     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/nchembio1108-648     Document Type: Short Survey

References (12)

1. Manning, G., Whyte, D.B., Martinez, R., Hunter, T. & Sudarsanam, S. Science 298, 1912-1934 (2002).
2. Knight, Z.A. & Shokat, K.M. Chem. Biol. 12, 621-637 (2005).
3. Bain, J. et al. Biochem. J. 408, 297-315 (2007).
4. Apsel, B. et al. Nat. Chem. Biol. 4, 691-699 (2008).
5. Sebolt-Leopold, J.S. & English, J.M. Nature 441, 457-462 (2006).
6. Petrelli, A. & Giordano, S. Curr. Med. Chem. 15, 422-432 (2008).
7. Quintas-Cardama, A., Kantarjian, H. & Cortes, J. Nat. Rev. Drug Discov. 6, 834-848 (2007).
8. Marone, R., Cmiljanovic, V., Giese, B. & Wymann, M.P. Biochim. Biophys. Acta 1784, 159-185 (2008).
9. Hayakawa, M. et al. Bioorg. Med. Chem. Lett. 17, 2438-2442 (2007).
10. Fan, Q.W. et al. Cancer Cell 9, 341-349 (2006).
11. Raynaud, F.I. et al. Cancer Res. 67, 5840-5850 (2007).
12. Maira, S.M. et al. Mol. Cancer Ther. 7, 1851-1863 (2008).